Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | HSD11B1 | P28845 | 7/20 | 0.41 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.41 |
| ▸ | DRD2 | P14416 | 1/20 | 0.40 |
| ▸ | DRD4 | P21917 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | ACE | P12821 | 2/20 | 0.36 |
| ▸ | L3MBTL3 | Q96JM7 | 1/20 | 0.35 |
| ▸ | PRMT5 | O14744 | 1/20 | 0.35 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2824467 | 0.96 | NPC1 (0.56) | NPC1RAB9ASMN1; SMN2DPP7POLB | |
| SCHEMBL10752905 | 0.91 | DPP7 (0.51) | NPC1RAB9ASMN1; SMN2DPP7POLB | |
| SCHEMBL10591026 | 0.91 | DPP7 (0.51) | NPC1RAB9ASMN1; SMN2DPP7POLB | |
| SCHEMBL385345 | 0.87 | NPC1 (0.51) | NPC1RAB9ASMN1; SMN2DPP7POLB | |
| SCHEMBL1419834 | 0.87 | NPC1 (0.47) | NPC1RAB9ASMN1; SMN2DPP7POLB | |
| SCHEMBL4445192 | 0.87 | NPC1 (0.51) | NPC1RAB9ASMN1; SMN2DPP7POLB | |
| SCHEMBL13254845 | 0.87 | NPC1 (0.51) | NPC1RAB9ASMN1; SMN2DPP7POLB | |
| SCHEMBL10757334 | 0.85 | NPC1 (0.50) | NPC1RAB9ASMN1; SMN2DPP7POLB | |
| SCHEMBL14740663 | 0.84 | NPC1 (0.45) | NPC1RAB9ASMN1; SMN2DPP7POLB | |
| SCHEMBL19974288 | 0.84 | NPC1 (0.43) | NPC1RAB9ASMN1; SMN2DPP7POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4735440-A1 | KRAS INHIBITORS | Bristol-Myers Squibb Company (US) | 2026-05-06 | — | — | EP | disclosed |
| EP-4735439-A1 | KRAS INHIBITORS | Bristol-Myers Squibb Company (US) | 2026-05-06 | — | — | EP | disclosed |
| WO-2025006962-A1 | KRAS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-01-02 | — | — | WO | disclosed |
| WO-2025006967-A1 | KRAS INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-01-02 | — | — | WO | disclosed |
| EP-1817109-B1 | MIXED-MODAL ANION-EXCHANGE TYPE SEPARATION MATERIAL | MERCK PATENT GMBH (DE) | 2020-02-26 | — | — | EP | disclosed |
| US-7648636-B2 | A chromatographic support including an immobilized ligand which combines an anion-exchange domain comprising an oligocyclic aza compound with endocyclic nitrogen and a non-ionic, second binding domain to allow adjustment of the overall hydrophobicity/hydrophilicity; separation; purification; peptides | MERCK PATENT GMBH (DE) | 2010-01-19 | — | — | US | disclosed |
| US-20080164211-A1 | Mixed-Modal Anion-Exchanged Type Separation Material | MERCK PATENT GMBH (DE) | 2008-07-10 | — | — | US | disclosed |
| EP-1817109-A1 | MIXED-MODAL ANION-EXCHANGE TYPE SEPARATION MATERIAL | Merck Patent GmbH (DE) | 2007-08-15 | — | — | EP | disclosed |
| EP-1693108-A1 | Mixed-modal anion-exchange type separation material | MERCK PATENT GmbH (DE) | 2006-08-23 | — | — | EP | disclosed |
| WO-2006058623-A1 | MIXED-MODAL ANION-EXCHANGE TYPE SEPARATION MATERIAL | MERCK PATENT GMBH (DE) | 2006-06-08 | — | — | WO | disclosed |